Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-18 7:48 pm Purchase | 2021-01-27 | 13G | Crescent Biopharma, Inc. CBIO | Stonepine Capital Management, LLC | 5,438 6.900% | 3,322 (+157.03%) | Filing History |
| 2021-02-16 06:14 am Purchase | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | ACUTA CAPITAL PARTNERS LLC | 3,442 6.100% | 3,442 (New Position) | Filing History |
| 2021-02-12 5:00 pm Sale | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Stonepine Capital Management, LLC | 2,116 3.800% | -519 (-19.71%) | Filing History |
| 2021-02-12 3:18 pm Purchase | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Nantahala Capital Management, LLC | 4,729 8.400% | 2,012 (+74.05%) | Filing History |
| 2021-02-12 2:42 pm Purchase | 2021-02-16 | 13G | Crescent Biopharma, Inc. CBIO | DIMENSIONAL FUND ADVISORS LP | 2,003 3.600% | 152 (+8.21%) | Filing History |
| 2021-02-11 4:57 pm Sale | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Integrated Core Strategies (US) LLC | 1,734 3.100% | -85 (-4.66%) | Filing History |
| 2021-02-10 3:04 pm Purchase | 2021-01-31 | 13G | Crescent Biopharma, Inc. CBIO | BlackRock Inc. BLK | 3,429 4.400% | 13 (+0.38%) | Filing History |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | The Vanguard Group | 2,491 4.450% | 961 (+62.84%) | Filing History |
| 2021-02-04 5:28 pm Sale | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Mangrove Partners Master Fund Ltd. | 0 0.000% | -1,731 (Position Closed) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | BlackRock Inc. BLK | 3,416 6.100% | 2,716 (+388.05%) | Filing History |